A1I05

[(2~{R})-3-[(2~{S},3~{R},4~{R},5~{R},6~{R})-6-(hexadecanoyloxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-2-octadecanoyloxy-propyl] octadecanoate

Created:	2025-02-03
Last modified:	2026-01-28

Find Related PDB Entry
1 entries where A1I05 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	188
Chiral Atom Count	6
Bond Count	188
Aromatic Bond Count	0

2D diagram of A1I05

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	[(2~{R})-3-[(2~{S},3~{R},4~{R},5~{R},6~{R})-6-(hexadecanoyloxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-2-octadecanoyloxy-propyl] octadecanoate
Systematic Name (OpenEye OEToolkits)	[(2~{R})-3-[(2~{S},3~{R},4~{R},5~{R},6~{R})-6-(hexadecanoyloxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-2-octadecanoyloxy-propyl] octadecanoate
Formula	C₆₁ H₁₁₆ O₁₁
Molecular Weight	1,025.567
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	RDKit (grade2)	2023.09.6	CCCCCCCCCCCCCCCCCC(=O)OC[CH](CO[CH]1O[CH](COC(=O)CCCCCCCCCCCCCCC)[CH](O)[CH](O)[CH]1O)OC(=O)CCCCCCCCCCCCCCCCC
SMILES	CACTVS	3.385	CCCCCCCCCCCCCCCCCC(=O)OC[CH](CO[CH]1O[CH](COC(=O)CCCCCCCCCCCCCCC)[CH](O)[CH](O)[CH]1O)OC(=O)CCCCCCCCCCCCCCCCC
SMILES	OpenEye OEToolkits	2.0.7	CCCCCCCCCCCCCCCCCC(=O)OCC(COC1C(C(C(C(O1)COC(=O)CCCCCCCCCCCCCCC)O)O)O)OC(=O)CCCCCCCCCCCCCCCCC
Canonical SMILES	RDKit (grade2)	2023.09.6	CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](CO[C@H]1O[C@H](COC(=O)CCCCCCCCCCCCCCC)[C@H](O)[C@@H](O)[C@H]1O)OC(=O)CCCCCCCCCCCCCCCCC
Canonical SMILES	CACTVS	3.385	CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](CO[C@H]1O[C@H](COC(=O)CCCCCCCCCCCCCCC)[C@H](O)[C@@H](O)[C@H]1O)OC(=O)CCCCCCCCCCCCCCCCC
Canonical SMILES	OpenEye OEToolkits	2.0.7	CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](CO[C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)COC(=O)CCCCCCCCCCCCCCC)O)O)O)OC(=O)CCCCCCCCCCCCCCCCC
InChI	RDKit (grade2)	2023.09.6	InChI=1S/C61H116O11/c1-4-7-10-13-16-19-22-25-27-30-33-35-38-41-44-47-55(62)68-50-53(71-57(64)49-46-43-40-37-34-31-28-26-23-20-17-14-11-8-5-2)51-70-61-60(67)59(66)58(65)54(72-61)52-69-56(63)48-45-42-39-36-32-29-24-21-18-15-12-9-6-3/h53-54,58-61,65-67H,4-52H2,1-3H3/t53-,54+,58-,59+,60+,61-/m0/s1
InChI	InChI	1.06	InChI=1S/C61H116O11/c1-4-7-10-13-16-19-22-25-27-30-33-35-38-41-44-47-55(62)68-50-53(71-57(64)49-46-43-40-37-34-31-28-26-23-20-17-14-11-8-5-2)51-70-61-60(67)59(66)58(65)54(72-61)52-69-56(63)48-45-42-39-36-32-29-24-21-18-15-12-9-6-3/h53-54,58-61,65-67H,4-52H2,1-3H3/t53-,54+,58-,59+,60+,61-/m0/s1
InChIKey	RDKit (grade2)	2023.09.6	FOFDHSVOXDANPH-DCHOAZFQSA-N
InChIKey	InChI	1.06	FOFDHSVOXDANPH-DCHOAZFQSA-N

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.